The journey to regulatory approval requires expertise and precision. Our proprietary approach, the Rapid Innovate Model™, is a process designed to enhance our clients' success at pre-clinical and early-stage clinical phases to accelerate progress on the regulatory pathway. From discovery to regulatory approval, we provide comprehensive support to move your technology forward. #biotech #innovation #fda #clinicaltrials
InfinixBio
Biotechnology
Columbus, Ohio 1,592 followers
Accelerating Technology to Market
Über uns
InfinixBio operates as a Contract Research Organization working with Entrepreneurs, Biotech Incubators, Biotech Companies, and Investors. Our goals are to advance our clients’ technology from concept to reality, to improve how their product works, and/or adapt their product to meet unmet or unarticulated market needs. The team consists of 30+ experienced scientists - 16 Ph.D.’s - from across the globe with deep domain expertise in genes, proteins, and cells, and has delivered creative solutions to many difficult problems in Biotechnology product development. Our locations are in Athens and Columbus, Ohio near universities allowing us to have unique access to resources. We are also able to facilitate a diversity of expertise in problem resolution. “We’ve found that to deliver the best solutions to our clients, we rely on the great diversity of our people. People from different backgrounds and walks of life bring different perspectives enabling creative solutions to challenging problems.” -Nick Henderson, CEO
- Website
-
http://www.infinixbio.com
External link for InfinixBio
- Industrie
- Biotechnology
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Columbus, Ohio
- Typ
- In Privatbesitz
- Gegründet
- 2012
- Spezialitäten
- genetics, protein biochemistry, cell biology, microbiology, and antibodies
Standorte
-
Primäre
1507 Chambers Rd
Columbus, Ohio 43212, US
-
340 W State St
Athens, Ohio 45701, US
Employees at InfinixBio
Aktualisierungen
-
Our team at InfinixBio supports biotech firms in advancing drug development. After successfully developing a proprietary drug showing efficacy in mice, one firm partnered with us for preclinical bioanalysis and toxicology studies. Their platform targets drug delivery to specific tissues, optimizing safety and efficacy of immune-modulating biologics. We assisted in selecting animal species, conducting GLP-compliant bioanalysis assays, Anti-Drug-Antibody (ADA) testing, and supported FDA IND application submission. Discover how our successful proprietary technologies are shaping the future: 🔗 Read our case study here: https://ow.ly/fRpT50SMH99 #BiotechInnovation #TherapeuticDevelopment #HealthcareSolutions #InfinixBio
-
-
Learn how a leading biotechnology company successfully partnered with InfinixBio to engineer and deliver usable strains for their custom therapeutic antibodies. 🔗 Read the case study: https://ow.ly/tJP350SMH2z #Biotechnology #TherapeuticAntibodies #Innovation
-
-
July is Sarcoma Awareness Month 🎗️ At InfinixBio, we are committed to advancing research and treatment options for sarcoma, a rare and often aggressive form of cancer. Through innovative biotech solutions and collaborative research, we strive to improve patient outcomes and bring hope to those affected by sarcoma. Join us in raising awareness and supporting the fight against sarcoma. Together, we can make a difference. #SarcomaAwarenessMonth #SarcomaResearch #InfinixBio #CancerResearch #HopeForACure
-
Anti-drug antibodies (ADAs) can pose significant challenges in treatments with biologic drugs. The immune system may mistakenly identify these complex medications as threats, triggering the production of ADAs. These antibodies bind to the drug molecules, reducing their effectiveness and potentially leading to treatment failure or unwanted side effects. Some of these challenges include: 1. Immunogenicity 2. Assay Development 3. Cross-Reactivity 4. Impact On Drug Efficacy And Safety By studying how ADAs form and interact with biologic drugs, researchers aim to reduce their formation and enhance treatment success. Learn more about the impact of ADAs on biologic treatments: 🔗 https://ow.ly/C5q950SMGrs #BiologicDrugs #MedicalScience #Immunology
-
-
Navigating drug development involves significant challenges in pre-clinical hurdles, including rigorous testing, analysis, and evaluation of samples, meeting project deadlines, staying within budgets, and preparing FDA IND applications—all requiring precision and expertise. To overcome these challenges we: • Leverage proprietary technologies to streamline processes • Ensure reliable outcomes in drug development • Continuously innovate and support the transition from pre-clinical stages to successful clinical trials Share your experiences with these challenges in the comment section! or learn more about our innovative approaches at: https://lnkd.in/dqp8w6hF #DrugDevelopment #PreClinicalStudies #BiotechChallenges #Pharma #Research
This content isn’t available here
Access this content and more in the LinkedIn app
-
When biologic drugs are administered, the immune system may produce anti-drug antibodies (ADAs) against the medication. These ADAs can attach to the drug, diminishing its effectiveness and potentially leading to treatment failure. ADAs can vary in their impact, with some causing mild reactions while others can lead to severe consequences such as allergic reactions or loss of therapeutic response. InfinixBio explains the impact of ADAs on biologic treatments and highlights the importance of understanding them for successful therapy. Recognizing the presence and behavior of ADAs is crucial for optimizing biologic drug efficacy, ensuring patient safety, and guiding adjustments in treatment protocols. Moreover, the FDA requires the evaluation of ADAs for the approval of biologic drugs to the next stage, emphasizing their significance in the drug development process. #AntiDrugAntibodies #BiologicDrugs #MedicalScience
-
At InfinixBio, our diverse team of accomplished scientists collaborates closely with clients to ensure that projects are not only completed efficiently but also align with both time and budget constraints. Trust in our expertise to deliver high-quality results that advance your research objectives. #Biotech #Preclinical #preclinicaltrials #pharmacokinetics
-
Exploring the complexities of gene therapy, InfinixBio is at the forefront of assessing and managing immunogenicity to enhance therapy safety and effectiveness. Our expert team specializes in comprehensive immunogenicity assessments, utilizing cutting-edge bioanalytical techniques to study immune responses across various AAV serotypes. #GeneTherapy #BiotechInnovation #InfinixBio
-
-
We're dedicated to advancing gene therapy through comprehensive immunogenicity assessments. Specializing in AAV vectors, we provide detailed PK analysis, toxicology support, and develop both ADA and NAb assays. This meticulous approach helps us manage immune responses effectively, ensuring the safety and efficacy of therapies. Curious about how we support gene therapy projects? Visit our website to learn more about our critical role in the development of innovative treatments. #GeneTherapy #Immunogenicity #Biotech
-